CollPlant Biotechnologies (CLGN) Cash & Current Investments (2017 - 2025)

CollPlant Biotechnologies (CLGN) has 9 years of Cash & Current Investments data on file, last reported at $5.9 million in Q4 2025.

• Quarterly Cash & Current Investments fell 51.06% year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (down 51.06% YoY) and the FY2025 annual result came in at $5.9 million, down 51.06% from the prior year.
• Cash & Current Investments eased to $5.9 million in Q4 2025, from $11.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $47.7 million in Q2 2021 to a low of $5.9 million in Q4 2025.
• A 5-year average of $26.5 million and a median of $26.8 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2021 — Cash & Current Investments surged 1200.35% — and 2024, when it plunged 54.83%.
• Tracing CLGN's Cash & Current Investments over 5 years: stood at $43.5 million in 2021, then sank by 31.33% to $29.9 million in 2022, then fell by 9.94% to $26.9 million in 2023, then sank by 54.83% to $12.2 million in 2024, then sank by 51.06% to $5.9 million in 2025.
• The last three Cash & Current Investments figures came in at $5.9 million (Q4 2025), $11.7 million (Q2 2025), and $12.2 million (Q4 2024), per Business Quant data.